Clinical Trial Update: Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial [Phase 3]

View source ↗

Summary

A completed Phase 3 randomized controlled trial evaluating the efficacy and safety of Remdesivir and Tociluzumab for severe COVID-19 and related ARDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Remdesivir (remdesivir)
• Tociluzumab (tociluzumab)

Snippet

Sponsor: M Abdur Rahim Medical College and Hospital | Conditions: Covid19, Covid-19 ARDS | Phase 3 | Status: COMPLETED